President & CEOOfficers of the CorporationBoard of TrusteesFoundation BoardLeadership CouncilAbout Joslin ResearchAdvocacy & Gov't AffairsHistory
Managing DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsJoslin Clinical ResearchInfo for Healthcare ProfessionalsJoslin Clinical Guidelines50-Year Medalist Program
Adult ClinicPediatricsEye CareMake an AppointmentInfo for Healthcare ProfessionalsBillingPatient Portal
Directory of Joslin InvestigatorsDiabetes Research Center Alumni ConnectionVolunteer for Clinical Research Studies
Media RelationsNews ReleasesInside JoslinSocial Media
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternationalHealthcare ProfessionalsCommercialization and VenturesJoslin Institute for Technology Translation (JITT)
Give NowHigh Hopes FundWays to GivePlanned GivingEventsGet InvolvedCorporate & Foundation SupportOur DonorsDevelopment Team

Dr. Thomas Serwold Joins Joslin Research Team

Thomas Serwold, PhD, Joslin Research Faculty

Wednesday, December 16, 2009

In November, Thomas Serwold, Ph.D., joined Joslin as the newest junior faculty member. Dr. Serwold was formerly with the Stanford Institute for Stem Cell Biology and Regenerative Medicine at Stanford University Medical School, where he trained with Dr. Irving Weissman, the first scientist to isolate adult stem cells.

At Joslin, Dr. Serwold studies how the immune system’s T cells are generated and how they work—research that helps to shed light on what causes type 1 diabetes and other autoimmune diseases.

You can find more on his research here

Page last updated: September 01, 2015